(Q54355801)

28 May 2018

title

The role of LRRK2 in the regulation of monocyte adhesion to endothelial cells. (English)

1 reference

28 May 2018

0 references

Li Hongge

1

1 reference

28 May 2018

Guo Kexin

2

1 reference

28 May 2018

Mou Xiaojie

3

1 reference

28 May 2018

Xiong Nian

4

1 reference

28 May 2018

Huang Jinsha

5

1 reference

28 May 2018

publication date

1 May 2014

1 reference

28 May 2018

Journal of Molecular Neuroscience

published in

1 reference

28 May 2018

volume

55

1 reference

28 May 2018

issue

1

1 reference

28 May 2018

page(s)

233-239

1 reference

28 May 2018

https://scigraph.springernature.com/pub.10.1007/s12031-014-0312-9

exact match

0 references

cites work

Roc, a Ras/GTPase domain in complex proteins

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0312-9

LRRK2 and Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0312-9

Pathological features of cerebral cortical capillaries are doubled in Alzheimer's disease and Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0312-9

LRRK2 is involved in the IFN-gamma response and host response to pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0312-9

The Parkinson's disease-associated protein, leucine-rich repeat kinase 2 (LRRK2), is an authentic GTPase that stimulates kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0312-9

Parkinson's disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0312-9

Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0312-9

Blood-brain barrier dysfunction in parkinsonian midbrain in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0312-9

Recent advances in the genetics of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0312-9

LRRK2 inhibition attenuates microglial inflammatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0312-9

p53 protein, interferon-gamma, and NF-kappaB levels are elevated in the parkinsonian brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0312-9

Inflammatory process in Parkinson's disease: role for cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0312-9

Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0312-9

Kruppel-like factor 2 protects against ischemic stroke by regulating endothelial blood brain barrier function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0312-9

Kinase activity of mutant LRRK2 mediates neuronal toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0312-9

Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0312-9

Regulation of LRRK2 expression points to a functional role in human monocyte maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0312-9

Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0312-9

Endothelial Kruppel-like factor 4 protects against atherothrombosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0312-9

Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12031-014-0312-9

Leucine-rich repeat kinase 2 mutations and Parkinson's disease: three questions

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24788225

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Endothelial dysfunction, hemodynamic forces, and atherogenesis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24788225

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Interleukin (IL)-1 beta, IL-2, IL-4, IL-6 and transforming growth factor-alpha levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24788225

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S12031-014-0312-9

1 reference

28 May 2018

PubMed ID

24788225

1 reference

28 May 2018